|
ZNF17 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.325800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.750340E-02 |
| Normal-vs-Stage2 |
6.942600E-01 |
| Normal-vs-Stage3 |
2.158800E-01 |
| Normal-vs-Stage4 |
1.055440E-03 |
| Stage1-vs-Stage2 |
5.946100E-02 |
| Stage1-vs-Stage3 |
1.240650E-03 |
| Stage1-vs-Stage4 |
5.25010000029802E-07 |
| Stage2-vs-Stage3 |
6.180200E-01 |
| Stage2-vs-Stage4 |
4.919600E-02 |
| Stage3-vs-Stage4 |
8.782400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.007600E-01 |
| Normal-vs-AfricanAmerican |
6.102000E-01 |
| Normal-vs-Asian |
2.961200E-01 |
| Caucasian-vs-AfricanAmerican |
5.506000E-01 |
| Caucasian-vs-Asian |
2.424800E-01 |
| AfricanAmerican-vs-Asian |
1.818020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.141800E-01 |
| Normal-vs-Female |
3.982000E-01 |
| Male-vs-Female |
2.046800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.642800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.530000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.734800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.931180E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.197000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.729600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.673600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.049800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.057200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.065800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.242500E-03 |
| Normal-vs-Grade 2 |
1.105800E-02 |
| Normal-vs-Grade 3 |
2.409400E-01 |
| Normal-vs-Grade 4 |
5.642699999997E-05 |
| Grade 1-vs-Grade 2 |
2.022300E-02 |
| Grade 1-vs-Grade 3 |
7.365800E-04 |
| Grade 1-vs-Grade 4 |
3.43489999998781E-07 |
| Grade 2-vs-Grade 3 |
2.818500E-04 |
| Grade 2-vs-Grade 4 |
4.32320002019537E-09 |
| Grade 3-vs-Grade 4 |
3.797800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.986000E-04 |
| Normal-vs-ccB subtype |
2.203400E-01 |
| ccA subtype-vs-ccB subtype |
2.44359999999055E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.001200E-01 |
| Normal-vs-N1 |
8.31910000000935E-05 |
| N0-vs-N1 |
1.261580E-02 |
|
|
